The size of the breast imaging market in the Asia Pacific is estimated to be growing at a CAGR of 9.86% from 2021 to 2026 and worth USD 0.91 Billion by 2026 from USD 0.57 Billion in 2021.
The growing frequency of early detection of disease and the rising incidence of breast cancer are majorly driving the expansion of the breast imaging market in the APAC region. Furthermore, the increasing geriatric population and the government’s increased awareness about breast cancer treatment methods in rural areas are further expected to propel the breast imaging market forward. In addition, the growing focus on determining dense breast tissue using breast imaging techniques and the emergence of the most recent technological advancements in the medical field is purely intended to accelerate market growth potential during the forecast period.
The growing number of government organizations investing in the APAC breast imaging market, the growing urbanized population, and the growing number of research and development institutes introducing highly featured products is further anticipated to fuel the market's growth rate. In addition, an increase in healthcare spending and increased hospital construction activities with advanced equipment to improve diagnosis and therapy processes are directly promoting the market’s growth rate.
Changes in reimbursement policies and the emergence of advanced imaging technologies such as nuclear imaging, ultrasound, MRI, near-infrared optical imaging, and bioelectrical imaging are expected to boost the breast imaging market’s growth factors.
However, the high cost of breast imaging systems and budget constraints, and the fact that healthcare facilities are hesitant to invest in new or technologically advanced systems are expected to hamper the growth of the Asia Pacific breast imaging market. In addition, patients may experience psychological health issues due to radiation exposure, regulatory restrictions, and high installation and maintenance costs.
This research report on the APAC breast imaging market has been segmented and sub-segmented into the following categories:
The Asia Pacific breast imaging market is expected to grow at the fastest rate during the forecast period. Over the forecast period, acquisitions and new product development efforts in the developing regions of India and China are likely to propel the breast imaging market even higher. In addition, the factors such as improved healthcare infrastructure, increased investment, and multinational industrial expansion attempts to create awareness through medial tourism are propelling the market growth in the region. Another important factor driving the breast imaging market’s growth in the region is the region’s frequent breast screening programs, which help raise awareness about the necessity of early detection. This increase is likely to improve the country’s breast imaging industry, which will impact the APAC market as well. In addition, emerging countries like India, China, Australia, and South Korea are key industry participants, which are likely to accelerate market expansion.
China recorded the largest share of the APAC breast imaging market in 2020, and it is likely to continue its growth throughout the forecast period. The Increasing healthcare infrastructure, technological advancements in the healthcare sector, and improving the country’s breast imaging industry fuel market growth.
On the other hand, Japan is expected to grow significantly due to rising healthcare costs, infrastructure, and increasing healthcare spending. In addition, Japan’s healthcare system is transforming, resulting in expanding the service portfolio from preventative care to nursing care in disease management.
Similarly, the Indian breast imaging market is anticipated to account for a considerable share in the APAC market during the forecast period. Improving the healthcare sector, growing awareness, rising demand, and government initiatives through medical tourism are augmenting the market growth in the country.
KEY MARKET PLAYERS:
A few of the noteworthy companies leading the APAC Breast Imaging Market profiled in the report are Hologic, Inc., GE Healthcare, Siemens Healthcare, Philips Healthcare, Fujifilm Holdings Corporation Gamma Medica, Inc., Toshiba Corporation, Sonocine, Inc., Aurora Imaging Technology, Inc., and Dilon Technologies, Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Ionizing Technologies
188.8.131.52 Digital Mammography
184.108.40.206 3D Mammography
220.127.116.11 Molecular Breast-Specific Gamma Imaging (MBI/BSGI)
18.104.22.168 Positron Emission Tomography and Computed Tomography (PET-CT)
22.214.171.124 Cone-Beam Computed Tomography (CBCT)
126.96.36.199 Positron Emission Mammography (PEM)
5.1.3 Non-ionizing Technologies
188.8.131.52 Breast MRI
184.108.40.206 Breast Ultrasound
220.127.116.11 Automated Whole-Breast Ultrasound (AWBU)
18.104.22.168 Breast Thermography
22.214.171.124 Optical Imaging
5.1.4 Y-o-Y Growth Analysis, By Type
5.1.5 Market Attractiveness Analysis, By Type
5.1.6 Market Share Analysis, By Type
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Type
6.1.4 Market Attractiveness Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Type
6.1.5 Market Share Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Type
6.5 South Korea
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Hologic Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 Siemens Healthcare
8.4 Philips Healthcare
8.5 Fujifilm Holdings Corporation Gamma Medica Inc.
8.6 Toshiba Corporation
8.7 Sonocine Inc.
8.8 Aurora Imaging Technolog Inc.,
8.9 Dilon Technologies, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures